{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Myalgia and backpain of unexpected duration"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Abnormal nucleated red blood cell differential"}],"denoms":[{"counts":[{"groupId":"OG000","value":"237"}],"units":"Participants"}],"groups":[{"description":"Participants will donate granulocytes after receiving a combination of two drugs, G-CSF and dexamethasone\n\nG-CSF/dexamethasone: Twelve hours before each donation, participants will be injected with G-CSF and will take one dose of dexamethasone by mouth.\n\nApheresis machine: Participants will undergo a procedure using an apheresis machine for granulocyte collection. The procedure will last 3 to 4 hours and will involve the drawing of blood from each arm, the separation of granulocytes from the red cells and plasma in the machine, and the return of the red cells and plasma to the participants.","id":"OG000","title":"Granulocyte Donors"}],"paramType":"NUMBER","populationDescription":"237 subjects consented to G-CSF and dexamethasone administration prior to granulocyte donation.","reportingStatus":"POSTED","timeFrame":"Measured at Week 1 after G-CSF administration","title":"Serious Adverse Events in Granulocyte Donors","type":"SECONDARY","unitOfMeasure":"participants"}